Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-25 @ 4:17 AM
NCT ID:
NCT07103720
Eligibility Criteria:
Inclusion Criteria:
* Not have a history of an adverse reactions to midazolam, ketamine or ondansetron
* Ability to understand study procedures and to comply with them for the entire length of the study.
* Contraception is not necessary, and we will include women of reproductive capability.
Exclusion Criteria:
* Unstable patients.
* History of any adverse reaction (allergy or sensitivity) to midazolam, ketamine or ondansetron.
* Pregnant and Pediatric patients
* Inability or unwillingness of individual or legal guardian/representative to give written informed consent.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07103720
Study Brief:
Protocol Section:
NCT07103720